H Carstens, M Albertsson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/drug therapyAdenocarcinoma/physiopathologyAgedAntimetabolites, Antineoplastic/administration & dosageAntimetabolites, Antineoplastic/therapeutic useCapecitabineDeoxycytidine/administration & dosageDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDisease ProgressionEsophageal Neoplasms/drug therapyEsophageal Neoplasms/physiopathologyFluorouracil/administration & dosageFluorouracil/analogs & derivativesFluorouracil/therapeutic useHumansMaleTreatment Outcome
Substances: See more » Antimetabolites, AntineoplasticDeoxycytidineCapecitabineFluorouracil
Year: 2007 PMID: 17653915 DOI: 10.1080/02841860701203560
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089